Surf Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $6M

  • Investors
  • 17

Surf Therapeutics General Information

Description

Developer of neuromodulatory technology designed for the treatment of autoimmune disorders. The company's technology offers treatment for chronic inflammatory autoimmune disorders without using drugs by using the body's natural anti-inflammatory pathway to restore immune balance, enabling patients to get healthy, balanced, and free from the constraints of pharmaceutical-dependent treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1401 Lavaca Street
  • Suite 635
  • Austin, TX 78701
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1401 Lavaca Street
  • Suite 635
  • Austin, TX 78701
  • United States

Surf Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Surf Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 17-Mar-2026 $6M Completed Clinical Trials - Phase 2
3. Seed Round 01-Dec-2025 Completed Clinical Trials - Phase 2
2. Accelerator/Incubator 01-Jul-2023 Completed Clinical Trials - Phase 2
1. Accelerator/Incubator Completed Clinical Trials - Phase 2
To view Surf Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Surf Therapeutics Patents

Surf Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4820102-A1 Systems and methods for ultrasound neuromodulation of desired anatomical targets Pending 06-Dec-2023
US-12551730-B2 Systems and methods for ultrasound neuromodulation of desired anatomical targets Active 06-Dec-2023
US-20250360345-A1 Systems and methods for ultrasound neuromodulation of desired anatomical targets Active 06-Dec-2023
US-20260199710-A1 Systems and methods for ultrasound neuromodulation of desired anatomical targets Pending 06-Dec-2023
WO-2025122461-A1 Systems and methods for ultrasound neuromodulation of desired anatomical targets Inactive 06-Dec-2023 A61N7/00
To view Surf Therapeutics’s complete patent history, request access »

Surf Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Surf Therapeutics Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Capital Factory Accelerator/Incubator Minority
Device of Tomorrow Capital Venture Capital Minority
Elderberry Ventures Venture Capital Minority
Evoce Capital Growth/Expansion Minority
General Inception Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

Surf Therapeutics FAQs

  • When was Surf Therapeutics founded?

    Surf Therapeutics was founded in 2022.

  • Where is Surf Therapeutics headquartered?

    Surf Therapeutics is headquartered in Austin, TX.

  • What is the size of Surf Therapeutics?

    Surf Therapeutics has 10 total employees.

  • What industry is Surf Therapeutics in?

    Surf Therapeutics’s primary industry is Drug Discovery.

  • Is Surf Therapeutics a private or public company?

    Surf Therapeutics is a Private company.

  • What is Surf Therapeutics’s current revenue?

    The current revenue for Surf Therapeutics is .

  • How much funding has Surf Therapeutics raised over time?

    Surf Therapeutics has raised $6M.

  • Who are Surf Therapeutics’s investors?

    Capital Factory, Device of Tomorrow Capital, Elderberry Ventures, Evoce Capital, and General Inception are 5 of 17 investors who have invested in Surf Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process